Incretin-modulated beta cell energetics in intact islets of langerhans

Molecular Endocrinology

Volumn 28, Issue 6, 2014, Pages 860-871

  Hodson, David J ^a   Tarasov, Andrei I ^a   Brias, Silvia Gimeno ^a   Mitchell, Ryan K ^a   Johnston, Natalie R ^a   Haghollahi, Shahab ^a   Cane, Matthew C ^a   Bugliani, Marco ^b   Marchetti, Piero ^b   Bosco, Domenico ^c   Johnson, Paul R ^d,e   Hughes, Stephen J ^d,e   Rutter, Guy A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF PISA   (Italy)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; INCRETIN; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT CALCIUM CHANNEL; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CALCIUM TRANSPORT; CELL ENERGY; CELL FUNCTION; CELL METABOLISM; CONTROLLED STUDY; CYTOSOL; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; INSULIN RELEASE; LANGERHANS CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SPECIES DIFFERENCE; ADULT; ANIMAL; CALCIUM SIGNALING; ENERGY METABOLISM; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TISSUE CULTURE TECHNIQUE;

ADENOSINE TRIPHOSPHATE; ADULT; ANIMALS; CALCIUM SIGNALING; ENERGY METABOLISM; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HUMANS; INCRETINS; INSULIN-SECRETING CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MIDDLE AGED; RECEPTORS, GLUCAGON; SPECIES SPECIFICITY; TISSUE CULTURE TECHNIQUES;

EID: 84901941969     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1038     Document Type: Article

References (68)

1. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest. 2006;116:1802-1812.
2. Komatsu M, Schermerhorn T, Noda M, Straub SG, Aizawa T, Sharp GW. Augmentation of insulin release by glucose in the absence of extracellular Ca2+: new insights into stimulus-secretion coupling. Diabetes. 1997;46:1928-1938.
3. Henquin JC. The dual control of insulin secretion by glucose involves triggering and amplifying pathways in beta-cells. Diabetes Res Clin Pract. 93 Suppl. 2011;1:S27-S31.
4. Holz GG. Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. Diabetes. 2004;53:5-13.
5. Ammälä C, Ashcroft FM, Rorsman P. Calcium-independent potentiation of insulin release by cyclic AMP in single beta-cells. Nature. 1993;363:356-358.
6. Rutter GA, Leclerc I. The AMP-regulated kinase family: enigmatic targets for diabetes therapy. Mol Cell Endocrinol. 2009; 297:41-49.
7. Wollheim CB, Regazzi R. Protein kinase C in insulin releasing cells. Putative role in stimulus secretion coupling. FEBS Lett. 1990;268: 376-380.
8. Longuet C, Broca C, Costes S, Hani EH, Bataille D, Dalle S. Extracellularly regulated kinases 1/2 (p44/42 mitogen-activated protein kinases) phosphorylate synapsin I and regulate insulin secretion in the MIN6 beta-cell line and islets of Langerhans. Endocrinology. 2005;146:643-654.
9. Rutter GA. Nutrient-secretion coupling in the pancreatic islet betacell: recent advances. Mol Aspects Med. 2001;22:247-284.
10. Parker HE, Wallis K, le Roux CW, Wong KY, Reimann F, Gribble FM. Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion. Br J Pharmacol. 2012;165:414-423.
11. Tolhurst G, Zheng Y, Parker HE, Habib AM, Reimann F, Gribble FM. Glutamine triggers and potentiates glucagon-like peptide-1 secretion by raising cytosolic Ca2+ and cAMP. Endocrinology. 2011;152:405-413.
12. Aaboe K, Krarup T, Madsbad S, Holst JJ. GLP-1: physiological effects and potential therapeutic applications. Diabetes Obes Metab. 2008;10:994-1003.
13. Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab. 2013;17:819-837.
14. Tian G, Sandler S, Gylfe E, Tengholm A. Glucose-and hormoneinduced cAMP oscillations in α-and β-cells within intact pancreatic islets. Diabetes. 2011;60:1535-1543.
15. Tsuboi T, da Silva Xavier G, Holz GG, Jouaville LS, Thomas AP, Rutter GA. Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells. Biochem J. 2003;369:287-299.
16. Peyot ML, Gray JP, Lamontagne J, et al. Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic beta-cells. PloS One. 2009;4:e6221.
17. Hodson DJ, Mitchell RK, Bellomo EA, et al. Lipotoxicity disrupts incretin-regulated human β cell connectivity. J Clin Invest. 2013; 123:4182-4194.
18. Ravier MA, Leduc M, Richard J, et al. β-Arrestin2 plays a key role in the modulation of the pancreatic beta cell mass in mice. Diabetologia. 2014;57:532-541.
19. Ainscow EK, Rutter GA. Glucose-stimulated oscillations in free cytosolic ATP concentration imaged in single islet beta-cells: evidence for a Ca2+-dependent mechanism. Diabetes. Suppl 2002;51: S162-S170.
20. Rutter GA. Ca2(+)-binding to citrate cycle dehydrogenases. Int J Biochem. 1990;22:1081-1088.
21. Li J, Shuai HY, Gylfe E, Tengholm A. Oscillations of sub-membrane ATP in glucose-stimulated beta cells depend on negative feedback from Ca(2+). Diabetologia. 2013;56:1577-1586.
22. Eliasson L, Renstrom E, Ding WG, Proks P, Rorsman P. Rapid ATP-dependent priming of secretory granules precedes Ca(2+)-induced exocytosis in mouse pancreatic B-cells. J Physiol. 1997;503 (Pt 2):399-412.
23. Berg J, Hung YP, Yellen G. A genetically encoded fluorescent reporter of ATP:ADP ratio. Nature Methods. 2009;6:161-166.
24. Tarasov AI, Griffiths EJ, Rutter GA. Regulation of ATP production by mitochondrial Ca(2+). Cell Calcium. 2012;52:28-35.
25. Tarasov AI, Semplici F, Li D, et al. Frequency-dependent mitochondrial Ca(2+) accumulation regulates ATP synthesis in pancreatic β cells. Pflugers Arch. 2013;465:543-554.
26. Tarasov AI, Semplici F, Ravier MA, et al. The mitochondrial Ca2+ uniporter MCU is essential for glucose-induced ATP increases in pancreatic beta-cells. PloS One. 2012;7:e39722.
27. Diraison F, Parton L, Ferré P, et al. Over-expression of sterolregulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). Biochem J. 2004;378:769-778.
28. Ravier MA, Cheng-Xue R, Palmer AE, Henquin JC, Gilon P. Subplasmalemmal Ca(2+) measurements in mouse pancreatic beta cells support the existence of an amplifying effect of glucose on insulin secretion. Diabetologia. 2010;53:1947-1957.
29. Wideman RD, Yu IL, Webber TD, et al. Improving function and survival of pancreatic islets by endogenous production of glucagonlike peptide 1 (GLP-1). Proc Natl Acad Sci USA. 2006;103:13468-13473.
30. Rutter GA, Loder MK, Ravier MA. Rapid three-dimensional imaging of individual insulin release events by Nipkow disc confocal microscopy. Biochem Soc Trans. 2006;34:675-678.
31. Benninger RK, Zhang M, Head WS, Satin LS, Piston DW. Gap junction coupling and calcium waves in the pancreatic islet. Biophys J. 2008;95:5048-5061.
32. Stozer A, Dolensek J, Rupnik MS. Glucose-stimulated calcium dynamics in islets of Langerhans in acute mouse pancreas tissue slices. PloS One. 2013;8:e54638.
33. Halestrap AP. The mitochondrial permeability transition: its molecular mechanism and role in reperfusion injury. Biochem Soc Symp. 1999;66:181-203.
34. Luciani DS, Misler S, Polonsky KS. Ca2+ controls slow NAD(P)H oscillations in glucose-stimulated mouse pancreatic islets. J Physiol. 2006;572:379-392.
35. Wiederkehr A, Park KS, Dupont O, et al. Matrix alkalinization: a novel mitochondrial signal for sustained pancreatic beta-cell activation. EMBO J. 2009;28:417-428.
36. Serre V, Dolci W, Schaerer E, et al. Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3,5-monophosphate levels and beta-cell glucose competence. Endocrinology. 1998;139: 4448-4454.
37. Denton RM, McCormack JG. On the role of the calcium transport cycle in heart and other mammalian mitochondria. FEBS Lett. 1980;119:1-8.
38. Merrins MJ, Fendler B, Zhang M, Sherman A, Bertram R, Satin LS. Metabolic oscillations in pancreatic islets depend on the intracellular Ca2+ level but not Ca2+ oscillations. Biophys J. 2010;99:76-84.
39. Ren J, Sherman A, Bertram R, et al. Slow oscillations of KATP conductance in mouse pancreatic islets provide support for electrical bursting driven by metabolic oscillations. Am J Physiol Endocrinol Metab. 2013;305:E805-E817.
40. Hodson DJ, Molino F, Fontanaud P, Bonnefont X, Mollard P. Investigating and Modelling Pituitary Endocrine Network Function. J Neuroendocrinol. 2010;1217-1225.
41. Detimary P, Jonas JC, Henquin JC. Stable and diffusible pools of nucleotides in pancreatic islet cells. Endocrinology. 1996;137: 4671-4676.
42. Ravier MA, Güldenagel M, Charollais A, et al. Loss of connexin36 channels alters beta-cell coupling, islet synchronization of glucoseinduced Ca2+ and insulin oscillations, and basal insulin release. Diabetes. 2005;54:1798-1807.
43. Zhang Q, Galvanovskis J, Abdulkader F, et al. Cell coupling in mouse pancreatic beta-cells measured in intact islets of Langerhans. Philos Trans A Math Phys Eng Sci. 2008;366:3503-3523.
44. Bennett BD, Jetton TL, Ying G, Magnuson MA, Piston DW. Quantitative subcellular imaging of glucose metabolism within intact pancreatic islets. J Biol Chem. 1996;271:3647-3651.
45. Karaca M, Castel J, Tourrel-Cuzin C, et al. Exploring functional beta-cell heterogeneity in vivo using PSA-NCAM as a specific marker. PloS One. 2009;4:e5555.
46. Ramos LS, Zippin JH, Kamenetsky M, Buck J, Levin LR. Glucose and GLP-1 stimulate cAMP production via distinct adenylyl cyclases in INS-1E insulinoma cells. J Gen Physiol. 2008;132:329-338.
47. Holz GG, Kühtreiber WM, Habener JF. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature. 1993;361:362-365.
48. Kang G, Chepurny OG, Malester B, et al. cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells. J Physiol. 2006;573:595-609.
49. Kao JP, Tsien RY. Ca2+ binding kinetics of fura-2 and azo-1 from temperature-jump relaxation measurements. Biophys J. 1988;53: 635-639.
50. Pralong WF, Bartley C, Wollheim CB. Single islet beta-cell stimulation by nutrients: relationship between pyridine nucleotides, cytosolic Ca2+ and secretion. EMBO J. 1990;9:53-60.
51. Wiederkehr A, Szanda G, Akhmedov D, et al. Mitochondrial matrix calcium is an activating signal for hormone secretion. Cell Metab. 2011;13:601-611.
52. Liu J, Guo L, Yin F, Zhang Y, Liu Z, Wang Y. Geniposide regulates glucose-stimulated insulin secretion possibly through controlling glucose metabolism in INS-1 cells. PloS One. 2013;8:e78315.
53. Jensen MV, Joseph JW, Ronnebaum SM, Burgess SC, Sherry AD, Newgard CB. Metabolic cycling in control of glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab. 2008;295: E1287-1297.
54. Park JH, Kim SJ, Park SH, et al. Glucagon-like peptide-1 enhances glucokinase activity in pancreatic β-cells through the association of Epac2 with Rim2 and Rab3A. Endocrinology. 2012;153:574-582.
55. Prentki M, Matschinsky FM, Madiraju SR. Metabolic signaling in fuel-induced insulin secretion. Cell Metab. 2013;18:162-185.
56. Denton RM, Randle PJ. Citrate and the regulation of adipose-tissue phosphofructokinase. Biochem J. 1966;100:420-423.
57. 2+ uptake induces cyclic AMP generation in the matrix and modulates organelle ATP levels. Cell metabolism. 2013;17:965-975.
58. Rutter GA, Hodson DJ. Minireview: Intraislet Regulation of Insulin Secretion in Humans. Mol Endocrinol. 2013;27:1984-1995.
59. Hodson DJ, Romanò N, Schaeffer M, et al. Coordination of calcium signals by pituitary endocrine cells in situ. Cell Calcium. 2012; 51:222-230.
60. Ihm SH, Matsumoto I, Sawada T, et al. Effect of donor age on function of isolated human islets. Diabetes. 2006;55:1361-1368.
61. Zeng Y, Torre MA, Karrison T, Thistlethwaite JR. The correlation between donor characteristics and the success of human islet isolation. Transplantation. 1994;57:954-958.
62. Ghosh A, Ronner P, Cheong E, Khalid P, Matschinsky FM. The role of ATP and free ADP in metabolic coupling during fuel-stimulated insulin release from islet beta-cells in the isolated perfused rat pancreas. J Biol Chem. 1991;266:22887-22892.
63. Nicholls DG. Forty years of Mitchell's proton circuit: From little grey books to little grey cells. Biochim Biophys Acta. 2008;1777: 550-556.
64. Ravier MA, Rutter GA. Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic alpha-cells. Diabetes. 2005;54:1789-1797.
65. Owen MR, Halestrap AP. The mechanisms by which mild respiratory chain inhibitors inhibit hepatic gluconeogenesis. Biochim Biophys Acta. 1993;1142:11-22.
66. Yang NC, Ho WM, Chen YH, Hu ML. A convenient one-step extraction of cellular ATP using boiling water for the luciferinluciferase assay of ATP. Anal Biochem. 2002;306:323-327.
67. Sanchez-Cardenas C, Fontanaud P, He Z, et al. Pituitary growth hormone network responses are sexually dimorphic and regulated by gonadal steroids in adulthood. Proc Natl Acad Sci USA. 2010; 107:21878-21883.
68. Hodson DJ, Mitchell RK, Marselli L, et al. ADCY5 couples glucose to insulin secretion in human islets [published online April 16, 2014]. Diabetes. doi:10.2337/db13-1607.